Crossref
Serine Hydroxymethyltransferase in Cancer Cells
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry · 2025-12 · 19 (4) · 336-351
DOI: 10.1134/s1990750824601371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, online erschienen am 02.03.2026. Verfasst von L. A. Gavriliuk. Die Arbeit nennt 108 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gavriliuk, L. A. (2025). Serine Hydroxymethyltransferase in Cancer Cells. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 19(4), 336-351. https://doi.org/10.1134/s1990750824601371
Vancouver
Gavriliuk LA. Serine Hydroxymethyltransferase in Cancer Cells. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 2025;19(4):336-351. doi:10.1134/s1990750824601371
BibTeX
@article{Gavriliuk2025,
author = {Gavriliuk, L. A.},
title = {Serine Hydroxymethyltransferase in Cancer Cells},
journal = {Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry},
year = {2025},
volume = {19},
number = {4},
pages = {336--351},
doi = {10.1134/s1990750824601371}
}
EUVIMED